Publications and communications of Marie-Joëlle KAISER

DE SENY, D., Baiwir, D., BIANCHI, E., COBRAIVILLE, G., DEROYER, C., Poulet, C., MALAISE, O., PAULISSEN, G., KAISER, M.-J., Hauzer, J.-P., Mazzucchelli, G., DELVENNE, P., & MALAISE, M. (2022). New Proteins Contributing to Immune Cell Infiltration and Pannus Formation of Synovial Membrane from Arthritis Diseases. International Journal of Molecular Sciences, 23 (1), 434. doi:10.3390/ijms23010434

DE SENY, D., BIANCHI, E., Baiwir, D., COBRAIVILLE, G., Collin, C., Deliège, M., KAISER, M.-J., Mazzucchelli, G., Hauzeur, J.-P., DELVENNE, P., & MALAISE, M. (May 2020). Proteins involved in the endoplasmic reticulum stress are key players in synovitis of osteoarthritis, chronic pyrophosphate arthropathy and rheumatoid arthritis, and correlate with the histological inflammatory score [Poster presentation]. OARSI, Vienna, Austria.

MALAISE, M., CHAPELIER, N., DEWAEL, T., LEONORI, L., LEROY, M., Mailleux, E., André, B., Halleux, S., KAISER, M.-J., MALAISE, O., RIBBENS, C., RINKIN, C., VON FRENCKELL, C., & VOLDERS, A. (May 2020). Une révolution thérapeutique en rhumatologie : oui, mais… Revue Médicale de Liège, 75 (5-6), 369-375.

de Seny, D., Bianchi, E., Baiwir, D., COBRAIVILLE, G., Collin, C., Deliège, M., Kaiser, M.-J., Mazzucchelli, G., Hauzeur, J.-P., Delvenne, P., & Malaise, M. (2020). Proteins involved in the endoplasmic reticulum stress are modulated in synovitis of osteoarthritis, chronic pyrophosphate arthropathy and rheumatoid arthritis, and correlate with the histological inflammatory score. Scientific Reports, 10 (1). doi:10.1038/s41598-020-70803-7

DE SENY, D., BIANCHI, E., Baiwir, D., Mazzucchelli, G., DEROYER, C., CIREGIA, F., MALAISE, O., KAISER, M.-J., Hauzeur, J.-P., DELVENNE, P., & MALAISE, M. (09 December 2019). La protéomique synoviale identifie de nouvelles protéines corrélées au score inflammatoire histologique : comparaison entre arthrose, chondrocalcinose et polyarthrite rhumatöide [Paper presentation]. 32ème Congrès Français de Rhumatologie, Paris, France.

Fosse, P., KAISER, M.-J., Namur, G., DE SENY, D., Malaise, M., & Hustinx, R. (2018). (18)F- FDG PET/CT joint assessment of early therapeutic response in rheumatoid arthritis patients treated with rituximab. European Journal of Hybrid Imaging, 2 (1), 6. doi:10.1186/s41824-017-0022-y

Hauzeur, J.-P., Kaiser, M.-J., DEFLANDRE, E., Ribbens, C., & Rinkin, C. (2017). non OMERACT-expert rheumatologists sonographers and inter-ultrasound machine reliability of the OMERACT ultrasound scoring in rheumatoid arthritis in a clinical-based setting: a belgian study. In KBVR poster display and abstracts. Belgium: KBVR.

SIMONI, P., Gerard, L., KAISER, M.-J., RIBBENS, C., RINKIN, C., MALAISE, O., & Malaise, M. (2015). Use of Tomosynthesis for Detection of Bone Erosions of the Foot in Patients With Established Rheumatoid Arthritis: Comparison With Radiography and CT. American Journal of Roentgenology, (205), 364-370. doi:10.2214/AJR.14.14120

Vander Cruyssen, B., Durez, P., Westhovens, R., KAISER, M.-J., Hoffman, I., De Keyser, F., MIRA Study Group, & Malaise, M. (Other coll.). (10 September 2010). The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues of the optimization of rituximab treatment strategies. Arthritis Research and Therapy, 12 (5), 169. doi:10.1186/ar3129

FOSSE, P., KAISER, M.-J., NAMUR, G., Malaise, M., & HUSTINX, R. (2010). Assessment of early therapeutic response in anti-TNFα refractory rheumatoid arthritis with FDG PET/CT. European Journal of Nuclear Medicine and Molecular Imaging, 37 (SUPPL), 211.

Kaiser, M.-J., Hauzeur, J.-P., Blacher, S., Foidart, J.-M., Deprez, M., Rossknecht, A., & Malaise, M. (2009). Contrast-enhanced coded phase-inversion harmonic sonography of knee synovitis correlates with histological vessel density: 2 automated digital quantifications. Journal of Rheumatology, 36 (7), 1391-400. doi:10.3899/jrheum.080584

NAMUR, G., KAISER, M.-J., Deprez, M., MALAISE, M., & HUSTINX, R. (2008). Is FDG-PET/CT an early indicator of the clinical response to rituximab in rheumatoid arthritis ? Journal of Nuclear Medicine, 49 (SUPPL), 10.

Beckers, C., Jeukens, X., Ribbens, C., Andre, B., Marcelis, S., Leclercq, P., Kaiser, M.-J., Willems, J., Hustinx, R., & Malaise, M. (March 2006). F-18-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3. European Journal of Nuclear Medicine and Molecular Imaging, 33 (3), 275-280. doi:10.1007/s00259-005-1952-3

Relic, B., Benoit, V., Franchimont, N., Kaiser, M.-J., Hauzeur, J.-P., Gillet, P., Merville, M.-P., Bours, V., & Malaise, M. (2006). Peroxisome proliferator-activated receptor-gamma1 is dephosphorylated and degraded during BAY 11-7085-induced synovial fibroblast apoptosis. Journal of Biological Chemistry, 281 (32), 597-604. doi:10.1074/jbc.M512807200

BECKERS, C., BERNARD, C., KAISER, M.-J., RIBBENS, C., MALAISE, M., & HUSTINX, R. (2005). Time-course study of (F-18)-FDG uptake in psoriatic synovitis. Journal of Nuclear Medicine, 46 (SUPPL), 183.

Beckers, C., Ribbens, C., Andre, B., Marcelis, S., Kaye, O., Mathy, L., KAISER, M.-J., Hustinx, R., Willems, J., & Malaise, M. (June 2004). Assessment of disease activity in rheumatoid arthritis with 18F-FDG PET. Journal of Nuclear Medicine, 45 (6), 956-964.

Relic, B., Benoit, V., Franchimont, N., Ribbens, C., Kaiser, M.-J., Gillet, P., Merville, M.-P., Bours, V., & Malaise, M. (2004). 15-deoxy-delta12,14-prostaglandin J2 inhibits Bay 11-7085-induced sustained extracellular signal-regulated kinase phosphorylation and apoptosis in human articular chondrocytes and synovial fibroblasts. Journal of Biological Chemistry, 279 (21), 399-403. doi:10.1074/jbc.M314118200

Kaiser, M.-J., & Malaise, M. (2002). Déminéralisation et ostéoporose: une confusion sémantique. Revue Médicale de Liège, 57 (5), 274-279.

Kaiser, M.-J., & Malaise, M. (2002). Comment je traite ... une polyarthrite rhumatoïde. L'avènement d'une nouvelle ère thérapeutique: les anticorps anti-TNF-alpha. Revue Médicale de Liège, 57 (8), 486-492.

Ribbens, C., Martin y Porras, M., Franchimont, N., Kaiser, M.-J., Jaspar, J. M., Damas, P., Houssiau, F. A., & Malaise, M. (2002). Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment. Annals of the Rheumatic Diseases, 61 (2), 161-166. doi:10.1136/ard.61.2.161

Ribbens, C., Andre, B., Jaspar, J. M., Kaye, O., Kaiser, M.-J., De Groote, D., & Malaise, M. (2000). Matrix metalloproteinase-3 serum levels are correlated with disease activity and predict clinical response in rheumatoid arthritis. Journal of Rheumatology, 120 (1), 888-893.

Ribbens, C., Bonnet, V., Kaiser, M.-J., Andre, B., Kaye, O., Franchimont, N., De Groote, D., Beguin, Y., & Malaise, M. (2000). Increased synovial fluid levels of soluble CD23 are associated with an erosive status in rheumatoid arthritis (RA). Clinical and Experimental Immunology, 120 (1), 194-199. doi:10.1046/j.1365-2249.2000.01198.x

Kaiser, M.-J., Achour, I., Kecha, O., Goxe, B., De Groote, D., Lefebvre, P., & Geenen, V. (1995). Vieillissement, défenses immunitaires at axe somatotrope-facteurs de croissance apparentés à l'insuline. Médecine et Hygiène, 53, 1608-1610.